The Under-oil Open Microfluidic System enhances tumor cell-ECM interaction studies, improving anti-metastatic drug testing ...

Researchers say study represents a resource that could also help to dissect Y-gene functions in other tissues.

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

Fred Hutch scientist rapidly reduces lung tumors in mice with a tagging system that grabs cancer-causing proteins and hauls them out.

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...

The inflammasome, a group of immune proteins, prevents early cancer development by controlling stem cell proliferation, ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...